GCL.3.1
Overview:
Dual-conjugate immune checkpoint inhibitors for the treatment of various cancers
Quick Links
Dual-conjugate immune checkpoint inhibitors for the treatment of various cancers
Last modified: Aug 13, 2025
Copyright © 2025 Purdue University. All Rights Reserved.Trademark Statement.
Trademark | Accessibility | EA/EO | Integrity | Free Expression | College Scorecard | Privacy Policy | Contact Us